TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27543592

Group type: EXPERIMENTAL
Intervention: Outreach service for adult patients with AKI, delivered via a phone call, with or without a visit to the primary clinician, aiming at rapidly establishing the aetiology, correcting reversible causes and conducting further appropriate investigation.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Good standard care for patients with AKI in the control hospital and its area.
Number of subjects: 0
Study: 24519387

Group type: EXPERIMENTAL
Intervention: ET + ZOL (4 mg every 3 months for 2 years)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 70
Study: 20449757

Group type: COMPARATOR
Intervention: Healthy women
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: T2D Poor Control (HbA1c ≥ 7%)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: T2D Good Control (HbA1c < 7%)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: T2D (both subgroups)
Number of subjects: 21
Study: 20919668

Group type: EXPERIMENTAL
Intervention: Scalpel
Number of subjects: 218

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 218
Study: 18937897

Group type: EXPERIMENTAL
Intervention: Low-glycemic index (GI) diets
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-glycemic index (GI) diets
Number of subjects: 0
Study: 16870076

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with a commercial NRL extract
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 26
Study: 12811692

Group type: EXPERIMENTAL
Intervention: imatinib (Glivec, Novartis, Switzerland)
Number of subjects: 72
Study: 10980221

Group type: EXPERIMENTAL
Intervention: Perflutren (5 or 10 microl/kg)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 211
Study: 8784400

Group type: EXPERIMENTAL
Intervention: Manual anastomosis
Number of subjects: 154

Group type: COMPARATOR
Intervention: Mechanical anastomosis
Number of subjects: 154
Study: 1290769

Group type: EXPERIMENTAL
Intervention: Hypnotic relaxation
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Hypnotic induction
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Autogenic training
Number of subjects: 64
Study: 6539253

Group type: EXPERIMENTAL
Intervention: Caffeine-treated semen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (semen without caffeine)
Number of subjects: 60
Study: 31597690

Group type: EXPERIMENTAL
Intervention: Vaccine hesitancy screening (15-item PACV survey)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control (placebo survey items only)
Number of subjects: 156
Study: 29214336

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin A (BTA) injections within 5 days of primary closure
Number of subjects: 30

Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 30
Study: 27530285

Group type: EXPERIMENTAL
Intervention: 5 mg droperidol
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 10 mg droperidol
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 10 mg + 10 mg droperidol (repeated at 15 min)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Droperidol (5 mg and 10 mg)
Number of subjects: 41
Study: 24334641

Group type: EXPERIMENTAL
Intervention: Leflunomide (LEF) 16.6 ± 5.2 mg/d for 3.6 ± 2.2 years
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Leflunomide (LEF)
Number of subjects: 43
Study: 23146366

Group type: EXPERIMENTAL
Intervention: Bidirectional barbed suture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional sutures
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 19631391

Group type: EXPERIMENTAL
Intervention: 5-Hz left prefrontal rTMS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10-Hz left prefrontal rTMS
Number of subjects: 0
Study: 17999224

Group type: EXPERIMENTAL
Intervention: Cognitive anxiety intensity
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Somatic anxiety intensity
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Self-confidence intensity
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cognitive directional anxiety
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Direction
Number of subjects: 12
Study: 14671681

Group type: EXPERIMENTAL
Intervention: New formulation of 500 mg ASA and 30 mg PSE
Number of subjects: 18

Group type: COMPARATOR
Intervention: Preliminary formulation of ASA and PSE
Number of subjects: 18
Study: 11033842

Group type: EXPERIMENTAL
Intervention: bb genotype sarcoidosis patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VDR genotypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VDR gene polymorphism
Number of subjects: 0
Study: 8993754

Group type: EXPERIMENTAL
Intervention: IMREGR-1 treatment
Number of subjects: 0
Study: 1458046

Group type: EXPERIMENTAL
Intervention: Active Neuroelectric Therapy (NET)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo NET
Number of subjects: 43
Study: 6386019

Group type: EXPERIMENTAL
Intervention: Preservative-free morphine 2 mg in saline
Number of subjects: 150

Group type: COMPARATOR
Intervention: Saline alone
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Preservative-free morphine 4 mg in saline
Number of subjects: 150
Study: 30782586

Group type: EXPERIMENTAL
Intervention: Home treatment of COPD exacerbation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital treatment for COPD exacerbation
Number of subjects: 0
Study: 28602711

Group type: EXPERIMENTAL
Intervention: Decision-Aid (DA)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard-of-Care (SoC)
Number of subjects: 26
Study: 25759150

Group type: EXPERIMENTAL
Intervention: Experimental group (exposed to a general fatigue task)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (not exposed to a general fatigue task)
Number of subjects: 112
Study: 23724696

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy on PC 6 (Neiguan) and additional acupuncture points (PC 4, HT 7, PC 7, PC 5, PC 3, CV 17, CV 6, BL 15, L 20, BL 17, BL 23, BL 18, HT 5, ST 36)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional drug regimen (e.g., Nitroglycerine, Isosorbide mononitrate, Propranolol)
Number of subjects: 0
Study: 20546501

Group type: EXPERIMENTAL
Intervention: HIV/HCV co-infection
Number of subjects: 3143

Group type: COMPARATOR
Intervention: HIV mono-infection
Number of subjects: 3143
Study: 18799510

Group type: EXPERIMENTAL
Intervention: Transthoracic contrast echocardiography (TTCE)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Chest high-resolution computed tomography (HRCT)
Number of subjects: 299
Study: 16118648

Group type: EXPERIMENTAL
Intervention: High-fat meal with high saturated fatty acid (SFA) content
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-fat meal with low saturated fatty acid (SFA) content
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (fat-exclusion lunch, snack, and dinner)
Number of subjects: 18
Study: 16446341

Group type: EXPERIMENTAL
Intervention: Paclitaxel/carboplatin/gemcitabine (PCG)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Paclitaxel/carboplatin (PC)
Number of subjects: 324
Study: 11322160

Group type: EXPERIMENTAL
Intervention: Modified functional obstacle course (FOC)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Original functional obstacle course (FOC)
Number of subjects: 36
Study: 9162610

Group type: EXPERIMENTAL
Intervention: IRS-1 Gly(972)Arg mutation (n = 9)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: IRS-1 Ala(513)Pro mutation (n = 5)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Either one or both mutations (n = 13)
Number of subjects: 93

Group type: COMPARATOR
Intervention: No mutations (n = 80)
Number of subjects: 93
Study: 1343079

Group type: EXPERIMENTAL
Intervention: delta‐prednisone (1 mg/kg per day per os for 2 weeks)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control (no steroids)
Number of subjects: 168
Study: 6698348

Group type: EXPERIMENTAL
Intervention: Ethanol (1.2 g/kg) administered during three hours with cimetidine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ethanol (1.2 g/kg) administered during three hours without cimetidine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ethanol (1.2 g/kg) with cimetidine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ethanol (1.2 g/kg) without cimetidine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cimetidine administration
Number of subjects: 10
Study: 28277426

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30252786

Group type: EXPERIMENTAL
Intervention: Cephalomedullary hip screws (CMHS)
Number of subjects: 14415

Group type: COMPARATOR
Intervention: Sliding hip screws (SHS)
Number of subjects: 14415
Study: 27215502

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (GLY) 15.6 μg twice daily (b.i.d.)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Indacaterol (IND) 75 μg once daily (q.d.)
Number of subjects: 511
Study: 24367959

Group type: EXPERIMENTAL
Intervention: Model right hand
Number of subjects: 21

Group type: COMPARATOR
Intervention: Person's right hand
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study: 22752776

Group type: EXPERIMENTAL
Intervention: Subcutaneous BT088 (200 IU, 0.4 mL)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Intramuscular BT088 (200 IU, 0.4 mL)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 31
Study: 20471313

Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation) at 400μA perception threshold
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tRNS (transcranial random noise stimulation) at 1200μA perception threshold
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-stimulation trials
Number of subjects: 0
Study: 18342647

Group type: EXPERIMENTAL
Intervention: 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive (COC)
Number of subjects: 534

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 534
Study: 15929960

Group type: EXPERIMENTAL
Intervention: Palatal surgery (specific type not detailed)
Number of subjects: 35
Study: 12239650

Group type: EXPERIMENTAL
Intervention: Laparoscopic antireflux surgery (LARS) with major depression (MD)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Laparoscopic antireflux surgery (LARS) without major depression (non-MD)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Toupet fundoplication
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Laparoscopic antireflux surgery (LARS)
Number of subjects: 38
Study: 10233488

Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 383

Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 383

Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 383
Study: 8919896

Group type: EXPERIMENTAL
Intervention: Contrast injection during the application of 20 cm H2O positive airway pressure for 5 s (Manoeuvre I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Contrast injection during ventilation with PEEP (15 cm H2O), a tidal volume of 1,200 ml, and a respiratory rate of 6/min (Manoeuvre II)
Number of subjects: 80
Study: 1907075

Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion (105 grams total in 1050 millilitres solution)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion
Number of subjects: 9
Study: 31831473

Group type: EXPERIMENTAL
Intervention: Telemedicine visit using Diabetic (intervention cohort)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Face‐to‐face visits (control cohort)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Control cohort (face‐to‐face visits)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Intervention cohort (telemedicine visit)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Both cohorts
Number of subjects: 379
Study: 31060559

Group type: EXPERIMENTAL
Intervention: 100 mg thiamine
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 29238262

Group type: EXPERIMENTAL
Intervention: Supported exercise group (SE; CE plus upper back, neck, and shoulder exercises)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional low back exercise group (CE)
Number of subjects: 20
Study: 25815454

Group type: EXPERIMENTAL
Intervention: SPI-guided analgesia
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional analgesia
Number of subjects: 45
Study: 23249984

Group type: EXPERIMENTAL
Intervention: 1% lidocaine with epinephrine
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1% plain lidocaine
Number of subjects: 12
Study: 21425573

Group type: EXPERIMENTAL
Intervention: Integrated medical protocol (Chinese medical therapy plus conventional Western medical treatment)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Conventional Western medical treatment plus placebo
Number of subjects: 606
Study: 21094432

Group type: EXPERIMENTAL
Intervention: Healthy School Ethos intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peer-mediation or motivational sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participation in planning or delivering intervention activities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 17233787

Group type: EXPERIMENTAL
Intervention: 5 mg methyltestosterone (MT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 15147112

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Therapy (CBGT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 57
Study: 11772706

Group type: EXPERIMENTAL
Intervention: Stress management intervention
Number of subjects: 25

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 25
Study: 10518859

Group type: EXPERIMENTAL
Intervention: New and Improved Colgate Tartar Control Fluoride Toothpaste with Micro‐Cleaning Crystals
Number of subjects: 73

Group type: COMPARATOR
Intervention: Colgate Tartar Control Fluoride Toothpaste with Micro‐Cleaning Crystals
Number of subjects: 73
Study: 7814285

Group type: EXPERIMENTAL
Intervention: 5 mg/kg/day itraconazole (once daily)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 5 mg/kg/day itraconazole (twice daily)
Number of subjects: 7
Study: 2642622

Group type: EXPERIMENTAL
Intervention: Self-hypnosis with specific suggestions for control of saliva immunoglobulins (Group B)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Self-hypnosis with permission to increase immune substances in saliva (Group A)
Number of subjects: 57

Group type: COMPARATOR
Intervention: No instructions but received equal attention time (Group C)
Number of subjects: 57
Study: 824298

Group type: EXPERIMENTAL
Intervention: 5 mg TRH taken twice daily for four weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-20 mg TRH taken twice daily for five days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31595489

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg at night for 7 days
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 210
Study: 30848791

Group type: EXPERIMENTAL
Intervention: GIP (4 pmol/kg/min)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GLP-1 (1 pmol/kg/min)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GIP + GLP-1 (4 and 1 pmol/kg/min, respectively)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: OGTT (50-g oral glucose tolerance test)
Number of subjects: 17
Study: 26621050

Group type: EXPERIMENTAL
Intervention: Arm strength training (8-week program, 23 sessions)
Number of subjects: 42
Study: 26279104

Group type: EXPERIMENTAL
Intervention: Transcutaneous PTNS (voltage pulse intensity of 0 to 10 mA, pulse width of 200 μs, frequency of 20 Hz, 30 min weekly for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham group (no stimulation, patch electrodes applied)
Number of subjects: 40
Study: 23649787

Group type: EXPERIMENTAL
Intervention: Community Engagement and Planning (CEP)
Number of subjects: 1246

Group type: COMPARATOR
Intervention: Resources for Services (RS)
Number of subjects: 1246
Study: 21719935

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (n=23)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (unsupplemented, n=21)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Vitamin E to lipids ratio
Number of subjects: 44
Study: 19376270

Group type: EXPERIMENTAL
Intervention: Trial-experienced participants
Number of subjects: 116

Group type: COMPARATOR
Intervention: Trial-naïve participants
Number of subjects: 116
Study: 16432272

Group type: EXPERIMENTAL
Intervention: Milk thistle (900 mg) for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Black cohosh (80 mg) for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rifampin (600 mg) for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clarithromycin (1000 mg) for 7 days
Number of subjects: 0
Study: 12891970

Group type: EXPERIMENTAL
Intervention: Intranet-based guidelines
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no guidelines)
Number of subjects: 12
Study: 11204315

Group type: EXPERIMENTAL
Intervention: CA 125 serum levels
Number of subjects: 36

Group type: COMPARATOR
Intervention: ESR
Number of subjects: 36

Group type: COMPARATOR
Intervention: CRP
Number of subjects: 36
Study: 8671102

Group type: EXPERIMENTAL
Intervention: Instruction by practice assistants after the first video; 25 patients received instruction from trained practice assistants who had followed a one evening course about inhaler instruction.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no instruction) consisting of 23 patients who did not receive instruction.
Number of subjects: 48
Study: 1288512

Group type: EXPERIMENTAL
Intervention: Garlic preparation (900 mg of garlic powder standardized as to 1.3% alliin)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Bezafibrate (600 mg)
Number of subjects: 98
Study: 3875454

Group type: EXPERIMENTAL
Intervention: Inspiratory pressure support during spontaneous ventilation (IPSSV)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 26
Study: 30862293

Group type: EXPERIMENTAL
Intervention: Integrated depression-alcohol misuse cognitive-behaviour therapy (CBT)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Alcohol/depression single-focused interventions
Number of subjects: 220

Group type: COMPARATOR
Intervention: Brief interventions
Number of subjects: 220
Study: 30416018

Group type: EXPERIMENTAL
Intervention: 2008-2009 Fluzone®
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fluarix®
Number of subjects: 100
Study: 27756485

Group type: EXPERIMENTAL
Intervention: Vaccine (Merck Adenovirus‐5 Gag/Pol/Nef HIV‐1 subtype‐B vaccine)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 43
Study: 23475226

Group type: EXPERIMENTAL
Intervention: Yo-Yo Intermittent Recovery Test Level 1 (Yo-YoIR1)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 30-15 Intermittent Fitness Test (30-15IFT)
Number of subjects: 14
Study: 22307266

Group type: EXPERIMENTAL
Intervention: Upfront zoledronic acid (4 mg intravenously every 6 months)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Delayed zoledronic acid (4 mg intravenously every 6 months)
Number of subjects: 189
Study: 20601739

Group type: EXPERIMENTAL
Intervention: Sago-soy supplementation (52.5 g carbohydrate and 15 g protein)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sago supplementation (60 g carbohydrate)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 18479779

Group type: EXPERIMENTAL
Intervention: Confederate ate a large amount of M&Ms
Number of subjects: 102

Group type: COMPARATOR
Intervention: Confederate ate a small amount of M&Ms
Number of subjects: 102

Group type: COMPARATOR
Intervention: Confederate ate no M&Ms
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Normal-weight appearance condition
Number of subjects: 102

Group type: COMPARATOR
Intervention: Slim appearance condition
Number of subjects: 102
Study: 15760532

Group type: EXPERIMENTAL
Intervention: Combined decompression operation (tentorium cerebelli incised 2-4 cm, bone flap craniectomy decompression (10-15)cm x (15-17)cm)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Conventional temporoparietal craniectomy
Number of subjects: 97
Study: 12226784

Group type: EXPERIMENTAL
Intervention: Real-time visual kinematic feedback
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Verbal instruction
Number of subjects: 12

Group type: COMPARATOR
Intervention: Free walking
Number of subjects: 12
Study: 10470769

Group type: EXPERIMENTAL
Intervention: Change in ordering practice: No standing orders for routine daily morning chest radiographs; each radiograph requires a written order and clinical indication.
Number of subjects: 3727

Group type: COMPARATOR
Intervention: Routine daily chest radiographs (control phase)
Number of subjects: 3727
Study: 8530649

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion of 256 mIU/min for 2 h
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 16
Study: 2195152

Group type: EXPERIMENTAL
Intervention: Toothpaste and oral rinse containing sanguinaria extract and zinc chloride
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo products
Number of subjects: 60
Study: 399943

Group type: EXPERIMENTAL
Intervention: Adjuvant radiation therapy combined with surgical excision
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant radiation therapy
Number of subjects: 0
Study: 30875354

Group type: EXPERIMENTAL
Intervention: Continuous noninvasive blood pressure monitoring
Number of subjects: 312

Group type: COMPARATOR
Intervention: Routine vital-sign assessments
Number of subjects: 312
Study: 29559771

Group type: EXPERIMENTAL
Intervention: FDC of telmisartan 80 mg and S-amlodipine 5 mg (CKD-828)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Coadministration of individual agents (telmisartan and S-amlodipine)
Number of subjects: 48